Advertisement

Essential tremor: treatment with beta-adrenoceptor blocking drugs

  • J. F. Wilson
  • R. W. Marshall
  • A. Richens

Abstract

Essential tremor is a chronic disorder of movement. It shows a familial tendency and is more common in patients over the age of 50 years. The characteristics of the disease are well documented (for reviews see Critchley, 1972; Murray, 1981). Although patients suffering from clearly separate tremor-producing conditions such as Parkinson’s disease may occasionally be present in a group of essential tremor patients, when accurately diagnosed essential tremor is a monosymptomatic illness. That is not to say, however, that essential tremor patients are a homogeneous group. The variability in responsiveness to drug therapy that will be described suggests that a review of the current single classification may be in order. The tremor is an action or postural tremor, being absent when a limb is at rest. It can be seen in a limb held in a fixed position against gravity, the usual arrangement used during accelerometer recordings of tremor (Wilson et al., 1982). Patients may show additional intention tremors which increase in amplitude towards the end of intention movements. The tremor occurs in short bursts which correlate with electromyographic activity. The frequency of the tremor covers a range from some 6 to 12 Hz but an individual patient shows a generally stable frequency or pattern of frequencies when measured repeatedly over a period of time. Emotional and physical stress aggravate the tremor and this aspect of the disease presumably accounts for the limited effectiveness of anxiolytic agents such as chlordiazepoxide in the treatment of tremor (Critchley, 1972).

Keywords

Essential Tremor Muscle Spindle Lipid Solubility Postural Tremor Physiological Tremor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abila, B., Marshall, R. W., Wilson, J. F. and Richens, A. (1983). Do β-adrenoceptor blockers have peripheral or central effect in essential tremor? Br. J. Clin. Pharmacol., 16, 210P.Google Scholar
  2. Andrew, J. (1981). Surgery for involuntary movements. Br. J. Hosp. Med., 26, 522–8.PubMedGoogle Scholar
  3. Arnold, J. M. O., Johnston, G. D., Harron, D. W. G., Shanks, R. G. and McDevitt, D. G. (1982). The effect of ICI 118 551 on isoprenaline-induced β-adrenoceptor responses in man. Br. J. Clin. Pharmacol., 15, 133–4P.Google Scholar
  4. Balla, J. I. (1973). Treatment of essential tremor with propranolol. Lancet, 1, 205.CrossRefPubMedGoogle Scholar
  5. Banker, B. Q. and Girvin, J. P. (1971). The ultrastructural features of the mammalian muscle spindle. J. Neuropathol. Exp. Neurol., 30, 155–95.CrossRefPubMedGoogle Scholar
  6. Barbeau, A. (1973). Traitement du tremblement essentiel familial par le propranolol. Union Med. Can., 102, 899–902.PubMedGoogle Scholar
  7. Barcroft, H., Peterson, E. and Schwab, R. S. (1952). Actions of adrenaline and noradrenaline on the tremor of Parkinson’s disease. Neurology, 2, 154–60.CrossRefPubMedGoogle Scholar
  8. Bowman, W. C. and Nott, M. W. (1969). Actions of sympathomimetic amines and their antagonists on skeletal muscle. Pharmacol. Rev., 21, 27–72.PubMedGoogle Scholar
  9. Britt, C. W. and Peters, B. H. (1979). Metoprolol for essential tremor. New Engl. J. Med., 301, 331.PubMedGoogle Scholar
  10. Calma, I. and Kidd, G. L. (1962). The effect of adrenaline on muscle spindles in cat. Arch. Ital. Biol., 100, 381–93.PubMedGoogle Scholar
  11. Calzetti, S., Findley, L. J., Gresty, M. A., Perucca, E. and Richens, A. (1981). Metoprolol and propranolol in essential tremor: a double-blind, controlled study. J. Neurol. Neurosurg. Psychiatr., 44, 814–19.PubMedCentralCrossRefPubMedGoogle Scholar
  12. Calzetti, S., Findley, L. J., Gresty, M. A., Perucca, E. and Richens, A. (1983a). Effect of a single oral dose of propranolol on essential tremor. A doubleblind controlled study. Ann. Neurol., 13, 165–71.CrossRefPubMedGoogle Scholar
  13. Calzetti, S., Findley, L. J., Perucca, E. and Richens, A. (1982). Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor. J. Neurol. Neurosurg. Psychiatr., 45, 893–7.PubMedCentralCrossRefPubMedGoogle Scholar
  14. Calzetti, S., Findley, L. J., Perucca, E. and Richens, A. (1983b). The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged adminstration. J. Neurol. Neurosurg. Psychiatr., 46, 393–8.PubMedCentralCrossRefPubMedGoogle Scholar
  15. Constas, C. (1962). The effects of adrenaline, noradrenaline and isoprenaline on Parkinsonian tremor. J. Neurol. Neurosurg. Psychiatr., 25, 116–21.PubMedCentralCrossRefPubMedGoogle Scholar
  16. Critchley, E. (1972). Clinical manifestations of essential tremor. J. Neurol. Neurosurg. Psychiatr., 35, 365–72.PubMedCentralCrossRefPubMedGoogle Scholar
  17. Dietrichson, P. and Espen, E. (1979). The effect of timolol vs placebo in benign essential tremor. In Proceedings of the Timolol Intercontinental Symposium, Stockholm, October, 1979, Merck Sharp & Dohme International.Google Scholar
  18. Dietrichson, P. and Espen, E. (1981). Effects of timolol and atenolol on benign essential tremor: placebo-controlled studies based on quantitative tremor recording. J. Neurol. Neurosurg. Psychiatr., 44, 677–83.PubMedCentralCrossRefPubMedGoogle Scholar
  19. Dupont, E., Hansen, H. J. and Dalby, M. A. (1973). Treatment of benign essential tremor with propranolol. Acta Neurol. Scand., 49, 75–84.CrossRefPubMedGoogle Scholar
  20. Findley, L. J., Calzetti, S., Gresty, M. A. and Paul, E. A. (1981). Amplitude of benign essential tremor and response to propranolol. Lancet, 2, 479–80.CrossRefPubMedGoogle Scholar
  21. Findley, L. J. and Gresty, M. A. (1981). Tremor. Br. J. Hosp. Med., 26, 16–32.PubMedGoogle Scholar
  22. Foster, J. B., Longley, B. P. and Stewart-Wynne, E. G. (1973). Propranolol in essential tremor. Lancet, 1, 1455.CrossRefPubMedGoogle Scholar
  23. Gilligan, B. S. (1972). Propranolol in essential tremor. Lancet, 2, 980.CrossRefPubMedGoogle Scholar
  24. Gilligan, B. S., Veale, J. L. and Wodak, J. (1972). Propranolol in the treatment of tremor. Med. J. Aust., 1, 320–2.PubMedGoogle Scholar
  25. Growdon, J. H., Shahani, B. T. and Young, R. R. (1975). The effect of alcohol on essential tremor. Neurology, 25, 259–62.CrossRefPubMedGoogle Scholar
  26. Herring, A. B. (1964). Action of pronethalol on Parkinsonian tremor. Lancet, 2, 892.CrossRefPubMedGoogle Scholar
  27. Jefferson, D., Jenner, P. and Marsden, C. D. (1979a). Relationship between plasma propranolol concentration and relief of essential tremor. J. Neurol. Neurosurg. Psychiatr., 42, 831–7.PubMedCentralCrossRefPubMedGoogle Scholar
  28. Jefferson, D., Jenner, P. and Marsden, C. D. (1979b). β-Adrenoreceptor antagonists in essential tremor. J. Neurol. Neurosurg. Psychiatr., 42, 904–9.PubMedCentralCrossRefPubMedGoogle Scholar
  29. Jefferson, D. and Marsden, C. D. (1980). Metoprolol in essential tremor. Lancet, 1, 427.CrossRefPubMedGoogle Scholar
  30. Joyce, G. C. and Rack, P. M. H. (1974). The effects of load and force on tremor at the normal human elbow joint. J. Physiol., 240, 375–96.PubMedCentralCrossRefPubMedGoogle Scholar
  31. Lands, A. M., Arnold, A., McAuliff, J. P., Luduena, F. P. and Brown, T. G. (1967). Differentiation of receptor systems activated by sympathomimetic amines. Nature. 214. 597–8.CrossRefPubMedGoogle Scholar
  32. Larsen, T. A. and Teräväinen, H. (1981). Beta-blockers in essential tremor. Lancet, 2, 533.CrossRefPubMedGoogle Scholar
  33. Larsson, S. and Svedmyr, N. (1977). Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors. Scand. J. Resp. Dis., 58, 5–10.Google Scholar
  34. Lee, R. G. and Stein, R. B. (1981). Resetting of tremor by mechanical perturbations: a comparison of essential tremor and Parkinsonian tremor. Ann. Neurol., 10, 523–31.CrossRefPubMedGoogle Scholar
  35. Leigh, P. N., Marsden, C. D., Twomey, A. and Jefferson, D. (1981). Beta-adrenoceptor antagonists and essential tremor. Lancet, 1, 1106.CrossRefPubMedGoogle Scholar
  36. Lippold, O. C. J. (1970). Oscillation in the stretch reflex arc and the origin of the rhythmical 8–12 c/s component of physiological tremor. J. Physiol., 206, 359–82.PubMedCentralCrossRefPubMedGoogle Scholar
  37. Lippold, O. (1971). Physiological tremor. Sci. Am., 224, 65–73.CrossRefPubMedGoogle Scholar
  38. Ljung, O. (1979). Treatment of essential tremor with metoprolol. New Engl. J. Med., 301, 1005.PubMedGoogle Scholar
  39. Ljung, O. (1980). Metoprolol in essential tremor. Lancet, 1, 1032.CrossRefPubMedGoogle Scholar
  40. McAllister, R. G., Markesbery, W. R., Ware, R. W. and Howell, S. M. (1977). Suppression of essential tremor by propranolol: correlation of effect with drug plasma levels and intensity of beta-adrenergic blockade. Ann. Neurol., 1, 160–6.CrossRefPubMedGoogle Scholar
  41. McClure, C. G. and Davis, J. N. (1976). The effect of D-propranolol on action tremors. Trans. Am. Neurol. Assoc., 101, 269–70.PubMedGoogle Scholar
  42. McDevitt, D. G. (1977). The assessment of β-adrenoceptor blocking drugs in man. Br. J. Clin. Pharmacol., 4, 413–25.PubMedCentralCrossRefPubMedGoogle Scholar
  43. Marsden, C. D., Foley, T. H., Owen, D. A. L. and McAllister, R. G. (1967). Peripheral β-adrenergic receptors concerned with tremor. Clin. Sci., 33, 53–65.PubMedGoogle Scholar
  44. Marsden, C. D. and Meadows, J. C. (1970). The effect of adrenaline on the contraction of human muscle. J. Physiol., 207, 429–48.PubMedCentralCrossRefPubMedGoogle Scholar
  45. Marsden, C. D., Meadows, J. C. and Lowe, R. D. (1969). The influence of noradrenaline, tyramine and activation of sympathetic nerves on physiological tremor in man. Clin. Sci., 37, 243–52.Google Scholar
  46. Moore, R. Y. and Bloom, F. E. (1979). Central catecholamine neurone systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu. Rev. Neurosci., 2, 113–68.CrossRefPubMedGoogle Scholar
  47. Morgan, M. H., Hewer, R. L. and Cooper, R. (1973). Effect of the beta adrenergic blocking agent propranolol on essential tremor. J. Neurol. Neurosurg. Psychiatr., 36, 618–24.PubMedCentralCrossRefPubMedGoogle Scholar
  48. Murray, T. J. (1972). Treatment of essential tremor with propranolol. Can. Med. Assoc. J., 107, 984–6.PubMedCentralPubMedGoogle Scholar
  49. Murray, T. J. (1976). Long-term therapy of essential tremor with propranolol. Can. Med. Assoc. J., 115, 892–4.PubMedCentralPubMedGoogle Scholar
  50. Murray, T. J. (1981). Essential tremor. Can. Med. Assoc. J., 124, 1559–65.PubMedCentralPubMedGoogle Scholar
  51. Neil-Dwyer, G., Bartlett, J., McAinsh, J. and Cruickshank, J. M. (1981). β-Adrenoceptor blockers and the blood-brain barrier. Br. J. Clin. Pharmacol., 11, 549–53.PubMedCentralCrossRefPubMedGoogle Scholar
  52. Newman, R. P. and Jacobs, L. (1980). Metoprolol in essential tremor. Arch. Neurol., 37, 596–7.CrossRefPubMedGoogle Scholar
  53. Owen, D. A. L. and Marsden, C. D. (1965). Effect of adrenergic β-blockade on Parkinsonian tremor. Lancet, 2, 1259–62.CrossRefPubMedGoogle Scholar
  54. Paintal, A. S. (1964). Effects of drugs on vertebrate mechanoreceptors. Pharmacol. Rev., 16, 341–80.PubMedGoogle Scholar
  55. Pakkenberg, H. (1972). Propranolol in essential tremor. Lancet, 1, 633.CrossRefGoogle Scholar
  56. Perucca, E., Pickles, H. and Richens, A. (1981). Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects. Clin. Pharmacol. Ther., 29, 425–33.CrossRefPubMedGoogle Scholar
  57. Phillips, S. J., Richens, A. and Shand, D. G. (1973). Adrenergic control of tendon jerk reflexes in man. Br. J. Pharmacol., 47, 595–605.PubMedCentralCrossRefPubMedGoogle Scholar
  58. de Prada, M. and Zuercher, G. (1979). Radioenzymatic assay of plasma and urinary catecholamines in man and various animal species: physiological and pharmacological applications. In Albertini, A., de Prada, M. and Peskar, B. A. (eds), Radioimmunoassay of Drugs and Hormones in Cardiovascular Medicine, Elsevier/North-Holland Biomedical Press, Amsterdam.Google Scholar
  59. Rangel-Guerra, R. (1974). Treatment of benign essential tremor with a beta-adrenergic blocking agent (sotalol). In Snart, A. G. (ed), Advances in Beta-adrenergic Blocking Therapy — Sotalol, International Congress Series 341, Excerpta Medica, Amsterdam, V62–6.Google Scholar
  60. Riley, T. and Pleet, A. B. (1979). Metoprolol tartrate for essential tremor. New Engl. J. Med., 301, 663.PubMedGoogle Scholar
  61. Rinne, U. K. and Kaitaniemi, P. (1974). Sotalol in the treatment of essential tremor. In Snart, A. G. (ed.), Advances in Beta-adrenergic Blocking Therapy — Sotalol, International Congress Series 341, Excerpta Medica, Amsterdam, V56–61.Google Scholar
  62. Scopa, J., Longley, B. P. and Foster, J. B. (1973). Beta-adrenergic blockers in benign essential tremor. Curr. Ther. Res., 15, 48–51.PubMedGoogle Scholar
  63. Sevitt, I. (1971). The effect of adrenergic beta-receptor blocking drugs on tremor. Practitioner, 207, 677–8.PubMedGoogle Scholar
  64. Sevitt, I. (1974). A comparison of propranolol and benzhexol in essential tremor. Practitioner, 213, 91–6.PubMedGoogle Scholar
  65. Smith, C. M. (1963). Neuromuscular pharmacology, drugs and muscle spindles. Annu. Rev. Pharmacol., 3, 223–42.CrossRefGoogle Scholar
  66. Sϕrensen, P. S., Paulson, O. B., Steiness, E. and Jansen, E. C. (1981). Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels. Ann. Neurol., 9, 53–7.CrossRefGoogle Scholar
  67. Strang, R. R. (1965). Clinical trial with a beta-receptor antagonist (propranolol) in Parkinsonism. J. Neurol. Neurosurg. Psychiatr., 28, 404–6.PubMedCentralCrossRefPubMedGoogle Scholar
  68. Sweet, R. D., Blumberg, J., Lee, J. E. and McDowell, F. H. (1974). Propranolol treatment of essential tremor. Neurology, 24, 64–7.CrossRefPubMedGoogle Scholar
  69. Taylor, E. A., Jefferson, D., Carroll, J. D. and Turner, P. (1981). Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of β-adrenoceptor antagonists. Br. J. Clin. Pharmacol., 12, 549–59.PubMedCentralCrossRefPubMedGoogle Scholar
  70. Teräväinen, H., Fogelholm, R. and Larsen, A. (1976). Effect of propranolol on essential tremor. Neurology, 26, 27–30.CrossRefPubMedGoogle Scholar
  71. Teräväinen, M. D., Larsen, A. and Fogelholm, R. (1977). Comparison between the effects of pindolol and propranolol on essential tremor. Neurology, 27, 439–42.CrossRefPubMedGoogle Scholar
  72. Tolosa, E. S. and Loewenson, R. B. (1975). Essential tremor: treatment with propranolol. Neurology, 25, 1041–4.CrossRefPubMedGoogle Scholar
  73. Turnbull, D. M. and Shaw, D. A. (1980). Metoprolol in essential tremor. Lancet, 1, 95.CrossRefPubMedGoogle Scholar
  74. Vas, C. J. (1966). Propranolol in Parkinsonian tremor. Lancet, 1, 182–3.CrossRefPubMedGoogle Scholar
  75. Wilson, J. F., Marshall, R. W., Dunstan, F. D. J. and Richens, A. (1982). A microcomputer based technique for the assessment of hand tremor in man. Br. J. Clin. Pharmacol., 15, 158P.Google Scholar
  76. Winkler, G. F. and Young, R. R. (1971). The control of essential tremor by propranolol. Trans. Am. Neurol. Assoc., 96, 66–8.PubMedGoogle Scholar
  77. Winkler, G. F. and Young, R. R. (1974). Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties. New Engl. J. Med., 290, 984–8.CrossRefPubMedGoogle Scholar
  78. Young, R. R., Growdon, J. H. and Shahani, B. T. (1975). Beta-adrenergic mechanisms in action tremor. New Engl. J. Med., 293, 950–3.CrossRefPubMedGoogle Scholar
  79. Young, R. R. and Hagbarth, K. E. (1980). Physiological tremor enhanced by manoeuvres affecting the segmental stretch reflex. J. Neurol. Neurosurg. Psychiatr., 43, 248–56.PubMedCentralCrossRefPubMedGoogle Scholar
  80. van Zwieten, P. A. and Timmermans, P. B. M. W. M. (1979). Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol. J. Cardiovasc. Pharmacol., 1, 85–96.CrossRefPubMedGoogle Scholar

Copyright information

© J. F. Wilson, R. W. Marshall and A. Richens 1984

Authors and Affiliations

  • J. F. Wilson
  • R. W. Marshall
  • A. Richens

There are no affiliations available

Personalised recommendations